SAMPLE SALES Clause Samples

The SAMPLE SALES clause governs the terms under which samples of goods may be sold or provided to potential buyers. Typically, this clause outlines whether samples are provided free of charge, at a reduced price, or under specific conditions, and may specify limitations on the quantity or use of such samples. Its core function is to clarify the rights and obligations of both parties regarding sample transactions, thereby preventing misunderstandings and disputes over the handling and cost of product samples.
SAMPLE SALES. Exhibitor agrees that no sample sales activity will occur on the main show floor. Distribution of literature is confined to Exhibitor’s own space, and no canvassing or solicitation of business will be allowed. Product release in Gifts 2 Go and Artisans’ Showcase, where juried product may be sold on a daily basis, will be allowed. It is the responsibility of the Exhibitor to inform their customers of these regulations. Violations could result in possible expulsion.
View SourceView Similar (8)
SAMPLE SALES. In connection with Tenant's use of the Premises for sales as provided herein, Tenant, subject to, and upon compliance with this Article, Articles 5 and 9 and all Requirements, may sell sample and overstock merchandise and merchandise rejected by customers from the Premises; provided, however, that (i) such sales shall be private and by invitation only and shall not be publicly advertised, (ii) such sales shall not exceed five days in duration, (iii) Tenant shall endeavor (without liability for failure to do so) to give Landlord reasonable advance notice of the occurrence of any such sale, (iv) Tenant shall not conduct more than six such sales annually, which sales shall generally occur at substantially evenly spaced intervals throughout the year, and (v) Tenant, at Tenant's sole cost and expense, shall obtain and maintain any permits or licenses required, if any, by Requirements as a precondition to issuance of any such permits or licenses. In the event that Tenant shall use or permit the use of the Premises in a manner other than as permitted by this Section 2.2(d), and without limiting Landlord's other remedies hereunder, Tenant shall cease and desist such use within twenty-four hours after notice by Landlord to Tenant of such improper or unpermitted use, which notice may be oral.
View Source

Related to SAMPLE SALES

  • Product Sales Subject to Sections 10.3(c) and 10.3(d), Licensee agrees that it will not sell, offer for sale, or assist third parties (including Affiliates) in selling Product except for the sale and offer for sale of (A) TAF Product, TAF Combination Product, TDF Product and TDF Combination Product for use in the Field and in the countries of the TDF-TAF Territory, (B) COBI Product and COBI Combination Product for use in the Field and in the countries of the COBI Territory, and (C) EVG Product, EVG Combination Product and Quad Product for use in the Field and in the countries of the EVG-Quad Territory.‌ (i) Licensee agrees that during the period in which the Patents are valid and enforceable (on a Product-by-Product basis) it will prohibit its Distributors from selling Product (A) to any other wholesaler or distributor, (B) outside the Territory for which Licensee is licensed for sale of such Product pursuant to Section 2.2, or (C) for any purpose outside the Field. (ii) Licensee agrees that it will not administer the TAF Quad to humans, or sell the TAF Quad until Gilead has obtained marketing approval for the TAF Quad from the FDA. Licensee agrees that it will not administer EVG to humans, or sell Products containing EVG until Gilead has obtained marketing approval for an EVG Product from the FDA. Licensee agrees that it will not administer COBI to humans, or sell Products containing COBI until Gilead has obtained marketing approval for a COBI Product from the FDA. Licensee agrees that it will not administer TAF to humans, or sell Products containing TAF until Gilead has obtained marketing approval for a TAF Product from the FDA. If Gilead obtains marketing approval from the FDA for any Quad Product or a Combination Product containing TAF, COBI or EVG (“Approved Combination Product”) prior to obtaining marketing approval for a TAF Product, EVG Product or COBI Product from the FDA, then Licensee will be allowed to administer such Quad Product or such Approved Combination Product to humans, and sell such Quad Product or such Approved Combination Product from and after the date of such marketing approval from the FDA, but will not (A) administer to humans or sell Combination Products containing EVG other than such Quad Product or such Approved Combination Product until Gilead has obtained marketing approval from the FDA for an EVG Product, or (B) administer to humans or sell Combination Products containing COBI other than such Quad Product or such Approved Combination Product until Gilead has obtained marketing approval from the FDA for a COBI Product or (C) administer to humans or sell Combination Products containing TAF other than such Quad Product or such Approved Combination Product until Gilead has obtained marketing approval from the FDA for a TAF Product.

  • Net Sales The term “

  • Gross Sales Notwithstanding anything in the Lease to the contrary the definition of Gross Sales shall be as follows:

  • Required Vendor Sales Reporting By responding to this Solicitation, you agree to report to TIPS all sales made under any awarded Agreement with TIPS. Vendor is required to report all sales under the TIPS contract to TIPS. If the TIPS Member entity requesting a price from the awarded Vendor requests the TIPS contract, Vendor must include the TIPS Contract number on any communications with the TIPS Member entity. If awarded, you will be provided access to the Vendor Portal. To report sales, login to the TIPS Vendor Portal and click on the PO’s and Payments tab. Pages 3-7 of the Vendor Portal User Guide will walk you through the process of reporting sales to TIPS. Please refer to the TIPS Accounting FAQ’s for more information about reporting sales and if you have further questions, contact the Accounting Team at ▇▇▇▇▇▇▇▇▇▇@▇▇▇▇-▇▇▇.▇▇▇. The Vendor or vendor assigned dealers are responsible for keeping record of all sales that go through the TIPS Agreement and submitting same to TIPS.

  • Direct Sales The Manager will advise you promptly, on the Offering Date, as to the Securities purchased by you pursuant to the Underwriting Agreement that you will retain for direct sale. At any time prior to the termination of the applicable AAU, any such Securities that are held by the Manager for sale but not sold may, on your request and at the Manager’s discretion, be released to you for direct sale, and Securities so released to you will no longer be deemed held for sale by the Manager. You may allow, and Dealers may reallow, a discount on sales to Dealers in an amount not in excess of the Reallowance set forth in the applicable AAU. You may not purchase Securities from, or sell Securities to, any other Underwriter or Dealer at any discount or concession other than the Reallowance, except with the prior consent of the Manager.